Cervical cancer is the fourth most common cancer in women globally and is the second leading cause of cancer deaths among women aged 15-44 in China. Nearly all cervical cancer cases are caused by human papillomavirus (HPV). Thus, primary prevention of cervical cancer can be effectively achieved through the administration of HPV vaccines. This evidence pool aims to compile and analyze major domestic and international research findings and evidence related to HPV vaccines. It serves as high-quality, evidence-based support for policymakers, media, and other key stakeholders in facilitating advocacy efforts in China to enhance HPV vaccine coverage and promote an increase in vaccination rates.
Establishing this evidence pool and preparing the report received extensive support and assistance from various stakeholders. The project was funded by the Bill and Melinda Gates Foundation and led by the School of Public Health at Peking Union Medical College, with Dr. Luzhao Feng as the principal investigator and Dr. Mengmeng Jia as the project lead. Professor Shenglan Tang’s team at the Duke Global Health Institute, Duke University, provided technical support.
